AR024282A1 - Compuestos derivdos de piperidin-etanosulfonil, su empleo, procedimiento para prepararlos y medicamentos que los contienen - Google Patents
Compuestos derivdos de piperidin-etanosulfonil, su empleo, procedimiento para prepararlos y medicamentos que los contienenInfo
- Publication number
- AR024282A1 AR024282A1 ARP000102775A ARP000102775A AR024282A1 AR 024282 A1 AR024282 A1 AR 024282A1 AR P000102775 A ARP000102775 A AR P000102775A AR P000102775 A ARP000102775 A AR P000102775A AR 024282 A1 AR024282 A1 AR 024282A1
- Authority
- AR
- Argentina
- Prior art keywords
- etanosulfonil
- piperidin
- medications
- employment
- prepare
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99111126 | 1999-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR024282A1 true AR024282A1 (es) | 2002-09-25 |
Family
ID=8238316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000102775A AR024282A1 (es) | 1999-06-08 | 2000-06-05 | Compuestos derivdos de piperidin-etanosulfonil, su empleo, procedimiento para prepararlos y medicamentos que los contienen |
Country Status (38)
Country | Link |
---|---|
US (1) | US6310213B1 (es) |
EP (1) | EP1189886B1 (es) |
JP (1) | JP3645856B2 (es) |
KR (1) | KR100571162B1 (es) |
CN (1) | CN1142141C (es) |
AR (1) | AR024282A1 (es) |
AT (1) | ATE315025T1 (es) |
AU (1) | AU770787B2 (es) |
BR (1) | BR0011419A (es) |
CA (1) | CA2376091C (es) |
CO (1) | CO5160328A1 (es) |
CZ (1) | CZ299483B6 (es) |
DE (1) | DE60025348T2 (es) |
DK (1) | DK1189886T3 (es) |
EG (1) | EG26101A (es) |
ES (1) | ES2254183T3 (es) |
GC (1) | GC0000256A (es) |
GT (1) | GT200000089A (es) |
HK (1) | HK1046412B (es) |
HR (1) | HRP20010885B1 (es) |
HU (1) | HU228591B1 (es) |
IL (2) | IL146750A0 (es) |
JO (1) | JO2260B1 (es) |
MA (1) | MA26797A1 (es) |
MX (1) | MXPA01012585A (es) |
MY (1) | MY128818A (es) |
NO (1) | NO320613B1 (es) |
PA (1) | PA8496601A1 (es) |
PE (1) | PE20010218A1 (es) |
PL (1) | PL196053B1 (es) |
RS (1) | RS50033B (es) |
RU (1) | RU2242464C2 (es) |
SI (1) | SI1189886T1 (es) |
TN (1) | TNSN00125A1 (es) |
TR (1) | TR200103532T2 (es) |
TW (1) | TWI254043B (es) |
WO (1) | WO2000075109A1 (es) |
ZA (1) | ZA200109706B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2225330T3 (es) * | 2000-03-22 | 2005-03-16 | Hoffmann La Roche | Compuesto de piperidina y piperacina para empleo en el tratamiento de alzheimer. |
DE60105144T2 (de) * | 2000-04-20 | 2005-09-08 | F. Hoffmann-La Roche Ag | Pyrrolidin und piperidin derivate für die behandlung von neurodegenerativen erkrankungen |
PA8525601A1 (es) * | 2000-08-21 | 2002-04-25 | Hoffmann La Roche | Profarmacos de (3s,4s)-4-bencil-1-[2-(4-hidroxi-bencenosulfonil)-etil]-piperidin-3-ol |
EP1332363A4 (en) * | 2000-10-09 | 2007-08-29 | Kay Double | PROOF OF NEURODEGENERATIVE DISEASES |
US6951875B2 (en) | 2001-10-29 | 2005-10-04 | Hoffmann-La Roche Inc. | Conjugated aromatic compounds with a pyridine substituent |
US7005432B2 (en) * | 2002-05-16 | 2006-02-28 | Hoffman-La Roche Inc. | Substituted imidazol-pyridazine derivatives |
EP2254580A1 (en) * | 2008-03-27 | 2010-12-01 | EVOTEC Neurosciences GmbH | Methods for treating disorders using nmda nr2b-subtype selective antagonist |
WO2013012871A1 (en) * | 2011-07-18 | 2013-01-24 | Adolor Corporation | Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
TW202442646A (zh) * | 2023-04-20 | 2024-11-01 | 大陸商紐歐申醫藥(上海)有限公司 | 含氮雜環類化合物及其製備方法和應用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4410822A1 (de) * | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
TW498067B (en) * | 1996-07-19 | 2002-08-11 | Hoffmann La Roche | 4-hydroxy-piperidine derivatives |
-
2000
- 2000-05-24 TW TW089109992A patent/TWI254043B/zh not_active IP Right Cessation
- 2000-05-31 MX MXPA01012585A patent/MXPA01012585A/es active IP Right Grant
- 2000-05-31 ES ES00936835T patent/ES2254183T3/es not_active Expired - Lifetime
- 2000-05-31 RS YUP-865/01A patent/RS50033B/sr unknown
- 2000-05-31 TR TR2001/03532T patent/TR200103532T2/xx unknown
- 2000-05-31 WO PCT/EP2000/004953 patent/WO2000075109A1/en active IP Right Grant
- 2000-05-31 EP EP00936835A patent/EP1189886B1/en not_active Expired - Lifetime
- 2000-05-31 HU HU0201916A patent/HU228591B1/hu not_active IP Right Cessation
- 2000-05-31 CN CNB008086028A patent/CN1142141C/zh not_active Expired - Fee Related
- 2000-05-31 CA CA002376091A patent/CA2376091C/en not_active Expired - Fee Related
- 2000-05-31 DE DE60025348T patent/DE60025348T2/de not_active Expired - Lifetime
- 2000-05-31 IL IL14675000A patent/IL146750A0/xx active IP Right Grant
- 2000-05-31 JP JP2001501590A patent/JP3645856B2/ja not_active Expired - Fee Related
- 2000-05-31 BR BR0011419-7A patent/BR0011419A/pt not_active Application Discontinuation
- 2000-05-31 RU RU2001135806/04A patent/RU2242464C2/ru not_active IP Right Cessation
- 2000-05-31 SI SI200030793T patent/SI1189886T1/sl unknown
- 2000-05-31 AT AT00936835T patent/ATE315025T1/de active
- 2000-05-31 KR KR1020017015765A patent/KR100571162B1/ko not_active IP Right Cessation
- 2000-05-31 PL PL00352723A patent/PL196053B1/pl unknown
- 2000-05-31 AU AU52181/00A patent/AU770787B2/en not_active Ceased
- 2000-05-31 CZ CZ20014349A patent/CZ299483B6/cs not_active IP Right Cessation
- 2000-05-31 DK DK00936835T patent/DK1189886T3/da active
- 2000-06-02 US US09/585,755 patent/US6310213B1/en not_active Expired - Lifetime
- 2000-06-02 PE PE2000000547A patent/PE20010218A1/es not_active Application Discontinuation
- 2000-06-03 TN TNTNSN00125A patent/TNSN00125A1/fr unknown
- 2000-06-05 EG EG2000060739A patent/EG26101A/en active
- 2000-06-05 AR ARP000102775A patent/AR024282A1/es active IP Right Grant
- 2000-06-05 PA PA20008496601A patent/PA8496601A1/es unknown
- 2000-06-06 MY MYPI20002522A patent/MY128818A/en unknown
- 2000-06-07 JO JO200087A patent/JO2260B1/en active
- 2000-06-07 GT GT200000089A patent/GT200000089A/es unknown
- 2000-06-07 GC GCP2000702 patent/GC0000256A/en active
- 2000-06-07 CO CO00042340A patent/CO5160328A1/es unknown
-
2001
- 2001-11-26 IL IL146750A patent/IL146750A/en not_active IP Right Cessation
- 2001-11-26 ZA ZA200109706A patent/ZA200109706B/en unknown
- 2001-11-28 HR HR20010885A patent/HRP20010885B1/xx not_active IP Right Cessation
- 2001-12-04 NO NO20015920A patent/NO320613B1/no not_active IP Right Cessation
- 2001-12-07 MA MA26438A patent/MA26797A1/fr unknown
-
2002
- 2002-11-05 HK HK02108022.3A patent/HK1046412B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR028317A1 (es) | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion | |
AR010346A1 (es) | COMPUESTOS DERIVADOS DE BENZOFURANO; SUS USOS, Y COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE. | |
AR027998A1 (es) | Derivados de etilendiamina y los medicamentos y composiciones farmaceuticas que los contienen | |
MX238612B (es) | Compuestos que contienen superabsorbente. | |
MX9202748A (es) | Compuesto de arileter, proceso para su obtencion y composicion farmaceutica que los contiene. | |
DE69900356D1 (de) | Nitro-Isoharnstoffderivate | |
TR199901877A3 (tr) | Zararli eklem bacaklilarin imhasi için terkip. | |
MX9102500A (es) | Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
MX9102580A (es) | Nuevas benzodiacepinonas, procedimiento para su preparacion y composicion farmaceutica que las contiene. | |
NO20015510L (no) | Medikament for lokal påföring | |
PT1560826E (pt) | Compostos piridopirimidinona, seus processos de preparacao e composicoes farmaceuticas que os contem | |
MX9201847A (es) | Derivados heterociclicos de antiserotoninas, procedimiento para su preparacion y medicamentos que los contienen. | |
PT1187847E (pt) | Derivados de estreptograminas sua preparacao e as composicoes que os contem | |
ID29339A (id) | Alat pengantar obat, khususnya untuk pengantar androgen | |
PT1124567E (pt) | Composicoes tamponadas para dialise | |
AR024282A1 (es) | Compuestos derivdos de piperidin-etanosulfonil, su empleo, procedimiento para prepararlos y medicamentos que los contienen | |
PT1049706E (pt) | Novos penta-sacaridos os respectivos metodos de producao e as composicoes farmaceuticas que os contem | |
EE200200050A (et) | Benseenamiini derivaadid antikoagulantidena | |
PT1041966E (pt) | Composicoes farmaceuticas que compreendem zafirlukast | |
AR028122A1 (es) | Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones | |
AR025230A1 (es) | Procedimiento para preparar fosfonometilglicina. | |
AR028324A1 (es) | Nuevos compuestos de heterocicloalquilbenzociclobutano y heteroarilbenzociclobutano, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
PT1204675E (pt) | Derivados de estreptograminas, sua preparacao e composicoes que os contem. | |
AR016434A1 (es) | Procedimiento para preparar clorobenzoxazoles | |
PT1060749E (pt) | Composicao farmaceutica aquosa que contem tesosentan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FG | Grant, registration |